Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.

dc.contributor.author

Zhang, Ruoxin

dc.contributor.author

Zhou, Fei

dc.contributor.author

Cheng, Lei

dc.contributor.author

Yu, Alexandria

dc.contributor.author

Zhu, Meiling

dc.contributor.author

Wang, Mengyun

dc.contributor.author

Zhang, Zhuanxu

dc.contributor.author

Xiang, Jiaqing

dc.contributor.author

Wei, Qingyi

dc.date.accessioned

2019-05-01T19:04:34Z

dc.date.available

2019-05-01T19:04:34Z

dc.date.issued

2018-11

dc.date.updated

2019-05-01T19:04:33Z

dc.description.abstract

The benefits of platinum-based chemotherapy (PBC) on survival of esophageal squamous cell carcinoma (ESCC) patients are inexplicit due to the varied therapeutic effects. Nucleotide excision repair (NER) pathway plays a vital role in removing platinum-DNA adducts in tumor cells and hence may modulate the therapeutic effect and survival outcome. The present study assessed the associations of 26 potentially functional regulatory single nucleotide polymorphisms (rSNPs) in nine core NER genes with disease-free survival (DFS) and overall survival (OS) in 339 ESCC patients. We found that ERCC2 rs2097215 T and rs3916788 A, ERCC5 rs3759497 A and XPC rs3731054 C alleles were associated with unfavorable DFS. Patients carrying high-risk allele group (HRG, 5-8 risk alleles) had a significantly shorter DFS, compared with those carrying low-risk alleles (LRG, 0-4 risk alleles) [adjusted hazards ratio (HRadj ) = 1.64, 95%CI = 1.23-2.19, Padj  < 0.001]. Three of these SNPs (ie, ERCC2 rs2097215 T and rs3916788 A and ERCC5 rs3759497 A) were also significantly associated with a poorer OS (HRG vs LRG: HRadj  = 1.75, 95%CI = 1.23-2.47, Padj  = 0.002). The expression quantitative trait loci (eQTL) analysis revealed significant genotype-expression correlations for ERCC5 rs3759497 and ERCC2 2097215 and rs3916788, which suggest regulatory roles of these SNPs. It appears that these NER variants may independently or jointly exert an impact on survival outcome of Chinese ESCC patients undergoing adjuvant platinum-based therapy. Large studies are warranted to validate these findings.

dc.identifier.issn

0899-1987

dc.identifier.issn

1098-2744

dc.identifier.uri

https://hdl.handle.net/10161/18520

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

Molecular carcinogenesis

dc.relation.isversionof

10.1002/mc.22877

dc.subject

disease-free survival

dc.subject

overall survival

dc.subject

regulatory single nucleotide polymorphism

dc.title

Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.

dc.type

Journal article

duke.contributor.orcid

Wei, Qingyi|0000-0002-3845-9445

pubs.begin-page

1553

pubs.end-page

1565

pubs.issue

11

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Medicine, Medical Oncology

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

57

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ZhangR-NER-SNPs-Therapy-ESCC-MolCarcino-WeiQ-2018.pdf
Size:
1.6 MB
Format:
Adobe Portable Document Format
Description:
Published version